GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » EPS without NRI

China National Accord Medicines (SZSE:000028) EPS without NRI : ¥3.09 (TTM As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines EPS without NRI?

China National Accord Medicines's earnings per share without non-recurring items for the three months ended in Mar. 2024 was ¥0.77. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.09.

During the past 12 months, China National Accord Medicines's average earnings per share (NRI) Growth Rate was -3.20% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 1.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 3.40% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for China National Accord Medicines's EPS without NRI or its related term are showing as below:

SZSE:000028' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -38.2   Med: 15.25   Max: 94.1
Current: 1.1

During the past 13 years, China National Accord Medicines's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 94.10% per year. The lowest was -38.20% per year. And the median was 15.25% per year.

SZSE:000028's 3-Year EPS without NRI Growth Rate is ranked worse than
61.25% of 80 companies
in the Medical Distribution industry
Industry Median: 7.15 vs SZSE:000028: 1.10

China National Accord Medicines's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.70. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.92.

China National Accord Medicines's EPS (Basic) for the three months ended in Mar. 2024 was ¥0.70. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.92.


China National Accord Medicines EPS without NRI Historical Data

The historical data trend for China National Accord Medicines's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines EPS without NRI Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.48 2.66 2.86 2.56 2.75

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.88 0.68 0.78 0.77

Competitive Comparison of China National Accord Medicines's EPS without NRI

For the Medical Distribution subindustry, China National Accord Medicines's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's PE Ratio without NRI Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's PE Ratio without NRI falls into.



China National Accord Medicines EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Accord Medicines  (SZSE:000028) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


China National Accord Medicines EPS without NRI Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines